Accordingly, KCa3.1 channels may become predominant regulators of membrane potential and insulin secretion when functional KATP channels are absent, which makes these channels ideal as drug targets in CHI. This evidence concerns the gene KCNN4 and congenital isolated hyperinsulinism.